| id |
oapen-20.500.12657-39700
|
| record_format |
dspace
|
| spelling |
oapen-20.500.12657-397002020-06-23T11:40:56Z Adaptive Nutzenbewertung für Untersuchungs- und Behandlungsmethoden mit Medizinprodukten hoher Klassen Mühlbacher, Axel Juhnke, Christin assessment of benefit study design decision analysis bic Book Industry Communication::M Medicine::MB Medicine: general issues::MBN Public health & preventive medicine The GKV-VSG introduced for the first time the benefit assessment of examination and treatment methods with medical devices of high classes and invasive character. In the future, the decision on reimbursement will depend on the documentation of benefits and harm. Basically, the benefit assessment can be divided into three phases: measuring the causal effects of an intervention, evaluating the measured effects and deciding on the reimbursement of an aggregate overall benefit. In order to meet the requirements, adaptive study designs, the multi-criteria decision analysis and the adaptive benefit assessment represent a future-proof concept for quick access for patients to innovative treatment methods with high quality and safety. 2020-06-17T14:18:57Z 2020-06-17T14:18:57Z 2016 book ONIX_20200617_9783954664597_41 http://library.oapen.org/handle/20.500.12657/39700 ger application/pdf n/a adaptive-nutzenbewertung-fur-untersuchungs-und-behandlungsmethoden-mit-medizinprodukten-hoher-klassen.pdf MWV Medizinisch Wissenschaftliche Verlagsgesellschaft 10.32745/9783954664597 The GKV-VSG introduced for the first time the benefit assessment of examination and treatment methods with medical devices of high classes and invasive character. In the future, the decision on reimbursement will depend on the documentation of benefits and harm. Basically, the benefit assessment can be divided into three phases: measuring the causal effects of an intervention, evaluating the measured effects and deciding on the reimbursement of an aggregate overall benefit. In order to meet the requirements, adaptive study designs, the multi-criteria decision analysis and the adaptive benefit assessment represent a future-proof concept for quick access for patients to innovative treatment methods with high quality and safety. 10.32745/9783954664597 9401348f-9594-4fba-a966-b475c0b6e6f0 100 Berlin open access
|
| institution |
OAPEN
|
| collection |
DSpace
|
| language |
ger
|
| description |
The GKV-VSG introduced for the first time the benefit assessment of examination and treatment methods with medical devices of high classes and invasive character. In the future, the decision on reimbursement will depend on the documentation of benefits and harm. Basically, the benefit assessment can be divided into three phases: measuring the causal effects of an intervention, evaluating the measured effects and deciding on the reimbursement of an aggregate overall benefit. In order to meet the requirements, adaptive study designs, the multi-criteria decision analysis and the adaptive benefit assessment represent a future-proof concept for quick access for patients to innovative treatment methods with high quality and safety.
|
| title |
adaptive-nutzenbewertung-fur-untersuchungs-und-behandlungsmethoden-mit-medizinprodukten-hoher-klassen.pdf
|
| spellingShingle |
adaptive-nutzenbewertung-fur-untersuchungs-und-behandlungsmethoden-mit-medizinprodukten-hoher-klassen.pdf
|
| title_short |
adaptive-nutzenbewertung-fur-untersuchungs-und-behandlungsmethoden-mit-medizinprodukten-hoher-klassen.pdf
|
| title_full |
adaptive-nutzenbewertung-fur-untersuchungs-und-behandlungsmethoden-mit-medizinprodukten-hoher-klassen.pdf
|
| title_fullStr |
adaptive-nutzenbewertung-fur-untersuchungs-und-behandlungsmethoden-mit-medizinprodukten-hoher-klassen.pdf
|
| title_full_unstemmed |
adaptive-nutzenbewertung-fur-untersuchungs-und-behandlungsmethoden-mit-medizinprodukten-hoher-klassen.pdf
|
| title_sort |
adaptive-nutzenbewertung-fur-untersuchungs-und-behandlungsmethoden-mit-medizinprodukten-hoher-klassen.pdf
|
| publisher |
MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
|
| publishDate |
2020
|
| _version_ |
1771297405159866368
|
